Insider · CIK 0001806525
Nailesh Bhatt
director
Files at SONN (Sonnet BioTherapeutics Holdings, Inc.), PURR (Hyperliquid Strategies Inc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | PURR Hyperliquid Strategies Inc | AGrant or award Common Stock | +40,789 | $0.00 | $0 | 42,871 | Feb 11, 2026 |
| Dec 2, 2025 | PURR Hyperliquid Strategies Inc | JOther Common Stock | +2,082 | - | - | 2,082 | Dec 12, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -10,547 | - | - | 0 | Dec 3, 2025 |
| Jul 11, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +10,000 | - | - | 10,547 | Jul 15, 2025 |
| Dec 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +373 | - | - | 547 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.